| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
1 Cellular and Molecular Biology Graduate Program, 2 Department of Urology, 3 Michigan Urology Center, 4 Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan; and the 5 Department of Urology, University of Ulm, Ulm, Germany
Mutations in the NH2-terminal regulatory domain of the ß-catenin gene lead to aberrant stabilization and accumulation of the protein and increased TCF/LEF-dependent transcription. Although these mutations are common in some cancers, they are infrequent in prostate and breast cancer. We have found that metastatic prostate cancer specimens, obtained through a rapid autopsy tissue procurement program, expressed a novel Mr 75,000 proteolytic fragment of ß-catenin (ß-cat75). ß-Cat75 was also expressed in multiple prostate and breast cancer cell lines and was closely associated with the activity of the calcium-dependent protease, calpain. In a prostate cancer cDNA microarray, m-calpain RNA levels were found to be significantly increased in metastatic disease compared with normal prostate. We showed calpain-dependent generation of ß-cat75 in cell culture and in vitro. Molecular mapping revealed that calpain cleavage removed the NH2-terminal regulatory domain of the ß-catenin protein. Treatment of MCF-7 cells with ionomycin led to increased accumulation of ß-cat75 in the nucleus and TCF-dependent transcriptional activity. Overexpression of a similar ß-catenin fragment that lacks the NH2-terminal 132 amino acids and has transforming potential activated TCF-dependent transcription. Given the low frequency of mutation-induced activation of ß-catenin in prostate and breast cancers, proteolytic cleavage of ß-catenin by calpain may represent a novel mechanism by which the protein is activated during tumorigenesis.
This article has been cited by other articles:
![]() |
D. Osman, V. Gobert, F. Ponthan, O. Heidenreich, M. Haenlin, and L. Waltzer A Drosophila model identifies calpains as modulators of the human leukemogenic fusion protein AML1-ETO PNAS, July 21, 2009; 106(29): 12043 - 12048. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Read, M. Rahmani, S. Boroomand, S. Allahverdian, B. M. McManus, and P. S. Rennie Androgen Receptor Regulation of the Versican Gene through an Androgen Response Element in the Proximal Promoter J. Biol. Chem., November 2, 2007; 282(44): 31954 - 31963. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Pelley, K. Chinnakannu, S. Murthy, F. M. Strickland, M. Menon, Q. P. Dou, E. R. Barrack, and G. P.-V. Reddy Calmodulin-Androgen Receptor (AR) Interaction: Calcium-Dependent, Calpain-Mediated Breakdown of AR in LNCaP Prostate Cancer Cells Cancer Res., December 15, 2006; 66(24): 11754 - 11762. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Helfer, B. C. Boswell, D. Finlay, A. Cipres, K. Vuori, T. Bong Kang, D. Wallach, A. Dorfleutner, J. M. Lahti, D. C. Flynn, et al. Caspase-8 Promotes Cell Motility and Calpain Activity under Nonapoptotic Conditions. Cancer Res., April 15, 2006; 66(8): 4273 - 4278. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Mulholland, S. Dedhar, G. A. Coetzee, and C. C. Nelson Interaction of Nuclear Receptors with the Wnt/{beta}-Catenin/Tcf Signaling Axis: Wnt You Like to Know? Endocr. Rev., December 1, 2005; 26(7): 898 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Libertini, B. S. Robinson, N. K. Dhillon, D. Glick, M. George, S. Dandekar, J. P. Gregg, E. Sawai, and M. Mudryj Cyclin E Both Regulates and Is Regulated by Calpain 2, a Protease Associated with Metastatic Breast Cancer Phenotype Cancer Res., December 1, 2005; 65(23): 10700 - 10708. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-N. Song and E. P. Gelmann Interaction of {beta}-Catenin and TIF2/GRIP1 in Transcriptional Activation by the Androgen Receptor J. Biol. Chem., November 11, 2005; 280(45): 37853 - 37867. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Franco and A. Huttenlocher Regulating cell migration: calpains make the cut J. Cell Sci., September 1, 2005; 118(17): 3829 - 3838. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Benetti, T. Copetti, S. Dell'Orso, E. Melloni, C. Brancolini, M. Monte, and C. Schneider The Calpain System Is Involved in the Constitutive Regulation of {beta}-Catenin Signaling Functions J. Biol. Chem., June 10, 2005; 280(23): 22070 - 22080. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |